Gagnon Jean-François, Sanschagrin François, Jacob Simon, Provencher Louise, Morin Carol, Diorio Caroline
Service de Pathologie Département de biologie médicale, Université Laval, Québec, Canada.
Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):168-72. doi: 10.1097/PAI.0b013e3181f104a1.
Neutral-buffered formalin is the most commonly used tissue fixative in pathology laboratory. Among other fixatives, Bouin's solution has been used in several laboratories and is still in use for particular tissues. In this project, we determine if we can study breast clinical markers on archived Bouin-fixed tissue samples with immunohistochemistry (IHC) protocols optimized for tissue fixed in neutral-buffered formalin. To evaluate the concordance of IHC results between formalin-fixed and Bouin-fixed tissues, we calculated the concordance percentage and the κ statistic of 12 clinical IHC markers quantified by an automated system on breast cancer tissues fixed in neutral-buffered formalin and their corresponding tissues fixed in Bouin's solution. When positivity threshold of immunostaining was setup at ≥10% for both fixation conditions, we observed a concordance percentage of 83.9% (κ=0.65). However, when positivity threshold of immunostaining was lowered to 3% to 4% for Bouin-fixed tissues, concordance percentage was then of 96.8% (κ=0.92). Our data demonstrate that we can study IHC markers on archived Bouin-fixed tissue from patients with long clinical follow-up using IHC protocols optimized for formalin-fixed tissues after an adjustment of the positivity threshold of immunostaining quantified by an automated system.
中性缓冲福尔马林是病理实验室中最常用的组织固定剂。在其他固定剂中,Bouin氏液已在多个实验室中使用,并且仍用于特定组织。在本项目中,我们确定是否可以使用针对中性缓冲福尔马林固定的组织优化的免疫组织化学(IHC)方案,对存档的Bouin固定组织样本进行乳腺临床标志物研究。为了评估福尔马林固定和Bouin固定组织之间IHC结果的一致性,我们计算了由自动化系统对中性缓冲福尔马林固定的乳腺癌组织及其相应的Bouin氏液固定组织定量的12种临床IHC标志物的一致性百分比和κ统计量。当两种固定条件下免疫染色的阳性阈值均设定为≥10%时,我们观察到一致性百分比为83.9%(κ=0.65)。然而,当将Bouin固定组织的免疫染色阳性阈值降低至3%至4%时,一致性百分比则为96.8%(κ=0.92)。我们的数据表明,在通过自动化系统对免疫染色阳性阈值进行调整后,我们可以使用针对福尔马林固定组织优化的IHC方案,对具有长期临床随访的患者的存档Bouin固定组织进行IHC标志物研究。